(Q37362610)

19 August 2017

1 reference

title

Evaluating combination therapies for asthma: pros, cons, and comparative benefits (English)

1 reference

19 August 2017

0 references

1

Leif Bjermer

1 reference

19 August 2017

1 June 2008

1 reference

Therapeutic advances in respiratory disease

19 August 2017

1 reference

19 August 2017

2

1 reference

19 August 2017

3

1 reference

19 August 2017

149-161

1 reference

Relation of the perception of airway obstruction to the severity of asthma

19 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Personality profiles and breathlessness perception in outpatients with different gradings of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Allergic rhinitis and asthma: how important is the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Bronchoprotective effects of leukotriene receptor antagonists in asthma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persiste

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Can asthma control be improved by understanding the patient's perspective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Asthma drug adherence in a long term clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Fluticasone propionate/salmeterol combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Inhaled budesonide/formoterol combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Potential masking effects of salmeterol on airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

What is "more effective asthma control"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Asthma and cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092280

21 January 2018

Identifiers

DOI

10.1177/1753465808092280

1 reference

19 August 2017

1 reference

PubMed ID

19124367